Home/Filings/4/0001799191-25-000008
4//SEC Filing

Virnich Daniel 4

Accession 0001799191-25-000008

CIK 0001799191other

Filed

Mar 19, 8:00 PM ET

Accepted

Mar 20, 6:01 PM ET

Size

5.1 KB

Accession

0001799191-25-000008

Insider Transaction Report

Form 4
Period: 2025-03-19
Virnich Daniel
Chief Executive Officer
Transactions
  • Disposition to Issuer

    Common stock

    2025-03-19$0.89/sh10,261$9,122701,723 total
Footnotes (1)
  • [F1]The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units (RSUs) pursuant to a sell-to-cover provision included in the RSU Agreement.

Issuer

Oncology Institute, Inc.

CIK 0001799191

Entity typeother

Related Parties

1
  • filerCIK 0001891107

Filing Metadata

Form type
4
Filed
Mar 19, 8:00 PM ET
Accepted
Mar 20, 6:01 PM ET
Size
5.1 KB